Navigation Links
An Eye on Increase in Testicular Cancer

Pinpointing reasons behind the dramatic increase in testicular cancer, now the most common malignant cancer among 15-to-35-year-old Caucasian men, is the focus of a// five-year, $5.5 million National Cancer Institute (NCI) grant to Yale Public Health researcher Tongzhang Zheng.

Testicular cancer is increasing for unknown reasons and this study will provide important information on possible environmental, genetic and other risk factors,” said Zheng, professor and head of the Division of Environmental Health Sciences in the Department of Epidemiology and Public Health at Yale School of Medicine.

Zheng will collaborate with researchers at Harvard School of Public Health and the Fred Hutchinson Cancer Research Center to conduct a population-based, case-control study on men in Connecticut and Massachusetts. The researchers will determine whether exposure to environmental factors such as environmental hormone disruptors increases the risk of testicular cancer. They will measure the levels of these environmental compounds in 800 patients with testicular cancer and in an equal number of unaffected control subjects.

Because so little is known about the potential environmental causes of testicular cancer, Zheng said, the team will collect and evaluate information on various major suspected risk factors, such as past medical history, history of hernia, venereal diseases, and any medication with androgens and other hormones. They will also examine lifetime occupational history, tobacco smoking, alcohol consumption and dietary information.

“Recent studies show that environmental exposures may affect development of testicular cancer,” said Zheng. “Determining risk factors that lead to testicular cancer, however is complicated because genetic susceptibility may modify a person’s risk from environmental exposures. We will try to assess the potential gene environment interaction on the manifestations of the disease.”

Source-
'"/>




Page: 1 2

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Increase in sugar...decrease in brain function!!!
3. Increase in tobacco deaths
4. Increased Heart Attack Risk From Celebrex,Vioxx
5. Deep Sleep Doesnt Increase Memory
6. Allergy Risk Increased by Kerosene Use
7. IVF technique May Increase The Risk Of Birth Defects
8. Step Aerobics Increases good cholesterol
9. Increase in renal problems
10. Fewer teeth & Increased Ischemic Stroke risk
11. Painkillers Increase Risk of Miscarriage

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Eye Increase Testicular Cancer

(Date:11/30/2009)... , The European Association of Urology (EAU) and ...he fight against prostate cancer, have entered int...-term commitment to increase and improve,patient ...eases., Professor Per-Anders Abrahamsson, Secret...U affiliated partnership, Europa Uomo will gain ac...
(Date:11/30/2009)... CHICAGONovember 30, 2009A pet owner knows the en... especially in troubled times. Most pets are consi...eable companions. A growing body of research now d...ld development, elderly care, mental illness, phys...ry, and the rehabilitation of incarcerated youth a...
(Date:11/30/2009)... The University of Navarra Hospital has launched ... efficacy of an immunotherapy treatment. This appr...ines produced from healthy and tumour cells from t...lioblastomas, one of the most aggressive and frequ...ered to participating patients combined with the s...
(Date:11/30/2009)... Author of "My Two-Y...r raising children who love to eat everything. , ...-- Do you have a picky eater in your house? Do yo...altime? Three new short online videos – one...ners, and the third on answers for real-life paren...
(Date:11/30/2009)...Like a pothole that worsens over time, so do knees...ONDAY, Nov. 30 (HealthDay News) -- If you,re a mid...tball court or hockey rink, take note: A new study...ost the risk of internal knee damage that could le...e injuries occurred in middle-age people who showe...
Breaking Medicine News(10 mins):Health News:The therapeutic benefits of the human-animal bond 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 3
...mirror LLC, a Philadelphia-based company offering ...DNA testing, is announcing the launch of their inn... affordable, easy-to-use product, with its user-fr...l HIV disease progression. HIVmirror(TM) i...
...earth endures, seedtime and harvest, cold and heat...e." - (Genesis 8:22, The Bible ). ...metime now. Needless to say, we, the people, of th...g the environmental crisis began way back in the t...
...enter for Consumer Freedom (CCF) welcomed a new st...tric & Adolescent Medicine, which will contribute ... the supposed link between television food adverti...that "children do not currently see more food ads ...
...udies have already revealed that stress boosts the...ers disease, a new study on mice has now shown th...ress-induced increases. The study, reported...first studies to elaborate the basic biomolecular ...
...ted wheat germ extract inhibits estrogen positive ...than the world's best selling cancer drug, Tamoxi...kend at the 2007 meeting of the American Society o...cal trials. In the current study, Andras Telekes, ...
...ound that tumor cell activity in women differs acc...east cancer in younger women. Breast canc... to treatment in women under 50 as compared to old...searchers led by Carey Anders at the Duke Institut...
Other Medicine News:Health News:HIVmirror, LLC Launching Breakthrough Genetic Product for HIV Positive Consumer 2Health News:World Environment Day (International Polar Year) 2Health News:World Environment Day (International Polar Year) 3Health News:World Environment Day (International Polar Year) 4Health News:New Studies: Commercials Aren't Making Kids Fat 2Health News:Stress Protein Inactivation Cuts Alzheimer's Peptide in Mice 2Health News:Wheat Germ Extract Inhibits Breast Cancer in Study 2
(Date:11/30/2009)... , , INDIANAPOLIS, Nov. 30 /PRNew...tration (FDA) has approved Cymbalta® (duloxet...zed anxiety disorder (GAD) in adults, Eli Lilly an...ince generalized anxiety disorder can be a chronic...atients find a treatment option that is effective ...
(Date:11/30/2009)... , , THOUSAND OAKS, Calif., Nov. 30 /PR... today announced that it will present updated long...omiplostim) in adult chronic immune (idiopathic) t... will present the first Nplate study in a pediatri...tic syndromes (MDS) at the 2009 American Society o...
(Date:11/29/2009)... , , CHICAGO, Nov. 30 Rad...is from a remote location with the use of a handhe...ftware, according to a study presented today at th...rth America (RSNA). ,, "The goal is to improve...ell as to improve communications among different c...
Breaking Medicine Technology:FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5Amgen Highlights Data to be Presented at ASH 2Amgen Highlights Data to be Presented at ASH 3Amgen Highlights Data to be Presented at ASH 4Amgen Highlights Data to be Presented at ASH 5Amgen Highlights Data to be Presented at ASH 6Amgen Highlights Data to be Presented at ASH 7Amgen Highlights Data to be Presented at ASH 8Amgen Highlights Data to be Presented at ASH 9Amgen Highlights Data to be Presented at ASH 10Amgen Highlights Data to be Presented at ASH 11Smart Phones Allow Quick Diagnosis of Acute Appendicitis 2Smart Phones Allow Quick Diagnosis of Acute Appendicitis 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 1LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 2LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 1SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 2SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 3SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 5PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 1PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 2
..., Fla. , May 29 GlaxoSmithKline [NYSE: GSK] and ...ted States Food and Drug Administration,s (FDA) On...o three that the ARZERRA(TM) (ofatumumab) data are... patients with chronic lymphocytic leukemia (CLL) ...mtuzumab. Ofatumumab is an investigational treatme...
...VILLE, Pa., May 29 Wyeth Pharmaceuticals, a divis...minary data from two ongoing studies, one evaluati...umab (Herceptin(R), Roche) in HER-2 positive (ErbB...nvestigating neratinib safety and efficacy when gi...b) in patients with HER-2 dependent solid tumors. ...
Other Medicine Technology:FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 2FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 3FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 4FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 5New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 2New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 3New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 4New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 5
7121B Sony Medical Monitor
...ompletely new and revolutionary lens system. The u... size without distortion. The 115 field of view su...tion of the telescope. Beyond that a new quick loc... is introduced. It is the combination of outstandi...
...e the surgeon with an optimal work area and reduce...t and retinal surgery. Perfect Pupil Injectable is...pils which allows expansion of the pupil to 8mm co...gery, and allows the pupil to return to its normal...
Defiant 95% Bag Filter
Medicine Products: